MY8400092A - 21 halogenopregnane compounds - Google Patents

21 halogenopregnane compounds

Info

Publication number
MY8400092A
MY8400092A MY92/84A MY8400092A MY8400092A MY 8400092 A MY8400092 A MY 8400092A MY 92/84 A MY92/84 A MY 92/84A MY 8400092 A MY8400092 A MY 8400092A MY 8400092 A MY8400092 A MY 8400092A
Authority
MY
Malaysia
Prior art keywords
halogenopregnane
compounds
halogenopregnane compounds
Prior art date
Application number
MY92/84A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of MY8400092A publication Critical patent/MY8400092A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MY92/84A 1976-09-29 1984-12-30 21 halogenopregnane compounds MY8400092A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (fr) 1976-09-29 1976-09-29

Publications (1)

Publication Number Publication Date
MY8400092A true MY8400092A (en) 1984-12-31

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
MY92/84A MY8400092A (en) 1976-09-29 1984-12-30 21 halogenopregnane compounds

Country Status (24)

Country Link
JP (1) JPS5356652A (fr)
AT (3) AT363197B (fr)
AU (1) AU514200B2 (fr)
BE (1) BE859120A (fr)
CA (1) CA1101410A (fr)
CH (9) CH624967A5 (fr)
CY (1) CY1178A (fr)
DD (1) DD133150A5 (fr)
DE (1) DE2743069C2 (fr)
DK (1) DK146017C (fr)
ES (1) ES462763A1 (fr)
FR (1) FR2366311A1 (fr)
GB (1) GB1563638A (fr)
HK (1) HK16683A (fr)
HU (1) HU175218B (fr)
IE (1) IE46047B1 (fr)
IL (1) IL53012A (fr)
KE (1) KE3258A (fr)
LU (1) LU75903A1 (fr)
MY (1) MY8400092A (fr)
NL (1) NL7710089A (fr)
SE (1) SE436751B (fr)
SG (1) SG3383G (fr)
ZA (1) ZA775800B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
EP0523132A1 (fr) * 1990-03-27 1993-01-20 Schering Corporation PROCEDE DE DESHYDRATATION DE 9$g(a)-HYDROXY STEROIDES
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2473471A1 (fr) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Procede relatif a l'elaboration de 6-alpha-fluorocorticosteroides
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
AT363197B (de) 1981-07-10
BE859120A (fr) 1978-03-28
CH632521A5 (en) 1982-10-15
ZA775800B (en) 1978-08-30
IE46047L (en) 1978-03-29
FR2366311A1 (fr) 1978-04-28
CA1101410A (fr) 1981-05-19
DK146017C (da) 1983-10-24
JPS5356652A (en) 1978-05-23
CH625809A5 (en) 1981-10-15
CY1178A (en) 1983-06-10
DK146017B (da) 1983-05-24
GB1563638A (en) 1980-03-26
HU175218B (hu) 1980-06-28
AU2914877A (en) 1979-04-05
FR2366311B1 (fr) 1982-12-03
DE2743069C2 (de) 1987-03-05
IL53012A (en) 1982-05-31
ES462763A1 (es) 1978-05-16
HK16683A (en) 1983-05-27
AT363203B (de) 1981-07-27
NL7710089A (nl) 1978-03-31
IE46047B1 (en) 1983-02-09
SG3383G (en) 1983-09-09
AT363202B (de) 1981-07-27
CH632279A5 (en) 1982-09-30
CH625808A5 (en) 1981-10-15
ATA691077A (de) 1980-12-15
CH631999A5 (en) 1982-09-15
CH624967A5 (en) 1981-08-31
SE7706673L (sv) 1978-03-30
ATA151379A (de) 1980-12-15
IL53012A0 (en) 1977-11-30
DE2743069A1 (de) 1978-03-30
JPS6214557B2 (fr) 1987-04-02
ATA151279A (de) 1980-12-15
CH631998A5 (en) 1982-09-15
KE3258A (en) 1983-03-04
SE436751B (sv) 1985-01-21
LU75903A1 (fr) 1978-05-16
CH632000A5 (en) 1982-09-15
DD133150A5 (de) 1978-12-13
DK256977A (da) 1978-03-30
AU514200B2 (en) 1981-01-29
CH625810A5 (en) 1981-10-15

Similar Documents

Publication Publication Date Title
IL48824A0 (en) Thc-type compounds
JPS5363335A (en) Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound
JPS5576895A (en) Novel 4*66diioo*aminoglycosyl**1*33 diaminocycritols
JPS5297994A (en) Betaalactummcontaining compounds
JPS5317639A (en) Hexakisazo compounds
JPS5325567A (en) 22phenylaminooimidazolinee*2* compound
JPS52133974A (en) 1*33dihydrooheteroarylspiro*isobenzolane*
JPS5321159A (en) 1*55disubstitutedd22pyrrolidones
GB1539364A (en) 11-deoxy-11-oxaprostaglandin compounds
JPS537677A (en) 2*66methanoo2hh11 benzooxosines
MY8400092A (en) 21 halogenopregnane compounds
JPS52156897A (en) 77*alphaa*2*33dihydroo22oxoo1hh benzimidazolee11ylcarbonylamino** arylacetoamide*cephalospolines
JPS5365892A (en) 33*22aminoethylthio**66*11hydroxyethyl* 77oxoo11azabicyclo*3*2*0*heptt22 enee22carboxylate
JPS5373576A (en) Substituted 2*1*33benzothiadiazine compound
JPS52111590A (en) Novel cephalospoline compounds
ZA77691B (en) Novel 1-sulfonyl-5(6)-substituted-benzimidazoles
JPS52102286A (en) 1*3*44oxadiazoleamides
NZ183615A (en) 5(6)-heterocycly carbonyl-2-alkoxycarbonylamino-benzimidazoles
JPS52102227A (en) Haloalkylphosphate compounds
ZA772175B (en) Oxothia compounds
JPS52108960A (en) 24*255dihydroxycalcipherol
JPS5325588A (en) 1*2*3*4*5*66hexahydroo1*66 methanoo33benzoazocine
JPS5297990A (en) Cephalospoline compounds
JPS539731A (en) 2*55dichioroo44brophenylazii44 chlorophenylsulfide
JPS5356312A (en) 11*22tetrahydrofuryl**55fluorourasil inclusion compound